Regulation of SLD5 gene expression by miR-370 during acute growth of cancer cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Yamane, Keitaro ^a   Naito, Hisamichi ^a   Wakabayashi, Taku ^a   Yoshida, Hironori ^a   Muramatsu, Fumitaka ^a   Iba, Tomohiro ^a   Kidoya, Hiroyasu ^a   Takakura, Nobuyuki ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GINS4 PROTEIN, HUMAN; MICRORNA; MIRN370 MICRORNA, HUMAN; NONHISTONE PROTEIN;

ANIMAL; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL PROLIFERATION; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN; HUMAN; METABOLISM; MOUSE; PATHOLOGY; XENOGRAFT;

ANIMALS; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HETEROGRAFTS; HUMANS; MICE; MICRORNAS; NEOPLASM TRANSPLANTATION; URINARY BLADDER NEOPLASMS;

EID: 84981168995     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep30941     Document Type: Article

References (39)

1. Takayama, Y. et al. GINS, a novel multiprotein complex required for chromosomal DNA replication in budding yeast. Genes Dev. 17, 1153-1165 (2003).
2. Yabuuchi, H. et al. Ordered assembly of Sld3, GINS and Cdc45 is distinctly regulated by DDK and CDK for activation of replication origins. EMBO J. 25, 4663-4674 (2006).
3. Nakahara, I. et al. Up-regulation of PSF1 promotes the growth of breast cancer cells. Genes Cells. 15, 1015-1024 (2010).
4. Wen, J. Z. et al. Expression of PSF1 in colon cancer tissues and its effect on the proliferation of colon cancer cells. Zhonghua Wei Chang Wai Ke Za Zhi. 16, 70-74 (2013).
5. Zhang, J. et al. Knockdown of PSF1 expression inhibits cell proliferation in lung cancer cells in vitro. Tumour Biol. 36, 2163-2168 (2015).
6. Obama, K. et al. Up-regulation of PSF2, a member of the GINS multiprotein complex, in intrahepatic cholangiocarcinoma. Oncol Rep. 14, 701-706 (2005).
7. Nagahama, Y. et al. PSF3 marks malignant colon cancer and has a role in cancer cell proliferation. Biochem Biophys Res Commun. 392, 150-154 (2010).
8. Tane, S. et al. Significant role of Psf3 expression in non-small-cell lung cancer. Cancer Sci. 106, 1625-1634 (2015).
9. Mohri, T. et al. Requirement of SLD5 for early embryogenesis.2013, PLoS One. 8, e78961 (2013).
10. Gong, Z. Y. et al. DNA damage enhanced by the attenuation of SLD5 delays cell cycle restoration in normal cells but not in cancer cells. PLoS One. 9, e110483 (2014).
11. Gouge, C. A., Christensen T. W. Drosophila Sld5 is essential for normal cell cycle progression and maintenance of genomic integrity. Biochem Biophys Res Commun. 400, 145-150 (2010).
12. Cairns, P. et al. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 8, 1083-1085 (1993).
13. Hazra, A. et al. Benzoapyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Genes Chromosomes Cancer. 41, 330-338 (2004).
14. Williamson, M. P. et al. The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosomes Cancer. 9, 108-118 (1994).
15. Sheu, Y. J., Stillman, B. The Dbf4-Cdc7 kinase promotes S phase by alleviating an inhibitory activity in Mcm4. Nature. 463, 113-117 (2010).
16. El-Gamal, E. M., Gouida, M. S. Flow cytometric study of cell cycle and DNA ploidy in bilharzial bladder cancer. Clin Lab. 61, 211-218 (2015).
17. Eissa, S. et al. HER2/neu expression in bladder cancer: relationship to cell cycle kinetics. Clin Biochem. 38, 142-148 (2005).
18. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, function. Cell. 116, 281-297 (2004).
19. Lee, R. C. et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75, 843-854 (1993).
20. Friedman, R. C. et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
21. Friedländer, M. R. et al. Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol. 15, R57 (2014).
22. Bo, J. et al. microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 278, 786-792 (2011).
23. Yoshino, H. et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer. 104, 808-818 (2011).
24. Hu, Z. et al. MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met. Biochem Biophys Res Commun. 435, 82-87 (2013).
25. Jody, C. et al. Epigenetics and microRNAs. Pediatric Research 61, 24R-29R (2007).
26. Araujo, F. D. et al. Identification of initiation sites for DNA replication in the human dnmt1 (DNA-methyltransferase) locus. J Biol Chem. 274, 9335-9341 (1999).
27. Chen, M. F. et al. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLosOne. 8, e61904 (2013).
28. Pillaire, M. J. et al. A 'DNA replication' signature of progression and negative outcome in colorectal cancer. Oncogene. 29, 876-887 (2010).
29. Karim Labib and Agnieszka Gambus. A key role for the GINS complex at DNA replication forks. TREND in Cell Biology. Review 17, 271-278 (2007).
30. Sourvinos, G. et al. Genetic detection of bladder cancer by microsatellite analysis of p16, RB1 and p53 tumor suppressor genes. J Urol. 165 249-252 (2001).
31. Wang, C. et al. Up-regulation of p21 (WAF1/CIP1) by miRNAs and its implications in bladder cancer cells. FEBS Lett. 588, 4654-4664 (2014).
32. Wang, C. et al. Promoter-associated endogenous and exogenous small RNAs suppress human bladder cancer cell metastasis by activating p21 (CIP1/WAF1) expression. Tumour Biol. doi: 10.1007/s13277-015-4571-z (2015).
33. Kong, L. et al. Identification and characterization of mouse PSF1-binding protein SLD5. Biochem Biophys Res Commun. 339, 1204-1207 (2006).
34. Saito, Y. et al. Specific activation of microRNA-127 with down-regulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 9, 435-443 (2006).
35. An, F. et al. Silencing of miR-370 in human cholangiocarcinoma by allelic loss and interleukin-6 induced maternal to paternal epigenotype switch. PLoS One. 7, e45606 (2012).
36. Meng, F. et al. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene. 27, 378-386 (2008).
37. Pignot, G. et al. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Int J Cancer. 132, 2479-2491 (2013).
38. Ito, S. et al. Role of Tet proteins in 5 mC to 5 hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature. 466, 1129-1133 (2010).
39. Kidoya, H. et al. The apelin/APJ system induced maturation of the tumor vasculature and improves the efficiency of immune therapy. Oncogene. 31, 3254-3264 (2012).